CA1053152A - Isolation and purification of e. coli enterotoxin - Google Patents

Isolation and purification of e. coli enterotoxin

Info

Publication number
CA1053152A
CA1053152A CA238,673A CA238673A CA1053152A CA 1053152 A CA1053152 A CA 1053152A CA 238673 A CA238673 A CA 238673A CA 1053152 A CA1053152 A CA 1053152A
Authority
CA
Canada
Prior art keywords
coli
enterotoxin
gel
labile
serotype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA238,673A
Other languages
English (en)
French (fr)
Inventor
Eberhard Schutze
Rudolf Weil
Peter Mayer
Georg Laber
Friedrich Dorner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1467174A external-priority patent/CH612994A5/de
Priority claimed from CH604075A external-priority patent/CH615196A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1053152A publication Critical patent/CA1053152A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA238,673A 1974-11-01 1975-10-30 Isolation and purification of e. coli enterotoxin Expired CA1053152A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1467174A CH612994A5 (en) 1974-11-01 1974-11-01 Process for the preparation of coli enterotoxin
CH1645874 1974-12-11
CH1645974 1974-12-11
CH604075A CH615196A5 (en) 1975-05-12 1975-05-12 Purification process for coli enterotoxin

Publications (1)

Publication Number Publication Date
CA1053152A true CA1053152A (en) 1979-04-24

Family

ID=27428963

Family Applications (1)

Application Number Title Priority Date Filing Date
CA238,673A Expired CA1053152A (en) 1974-11-01 1975-10-30 Isolation and purification of e. coli enterotoxin

Country Status (16)

Country Link
JP (1) JPS5170810A (enrdf_load_stackoverflow)
AU (1) AU511934B2 (enrdf_load_stackoverflow)
CA (1) CA1053152A (enrdf_load_stackoverflow)
DD (1) DD124879A5 (enrdf_load_stackoverflow)
DE (1) DE2547224A1 (enrdf_load_stackoverflow)
DK (2) DK478575A (enrdf_load_stackoverflow)
ES (1) ES442242A1 (enrdf_load_stackoverflow)
FI (2) FI752964A7 (enrdf_load_stackoverflow)
FR (1) FR2289206A1 (enrdf_load_stackoverflow)
GB (1) GB1529871A (enrdf_load_stackoverflow)
IE (1) IE43702B1 (enrdf_load_stackoverflow)
IL (1) IL48384A (enrdf_load_stackoverflow)
NL (1) NL7512590A (enrdf_load_stackoverflow)
NO (1) NO753578L (enrdf_load_stackoverflow)
NZ (1) NZ179108A (enrdf_load_stackoverflow)
SE (1) SE8100404L (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738364B (en) * 1972-12-04 1974-09-25 Rit Rech Ind Therapeut Piglet colibacillosis vaccines and process for their preparation

Also Published As

Publication number Publication date
FI752964A7 (enrdf_load_stackoverflow) 1976-05-02
NO753578L (enrdf_load_stackoverflow) 1976-05-04
IE43702B1 (en) 1981-05-06
DK278478A (da) 1978-06-20
IE43702L (en) 1976-05-01
FR2289206B1 (enrdf_load_stackoverflow) 1978-11-10
SE8100404L (sv) 1981-01-23
IL48384A0 (en) 1976-03-31
FR2289206A1 (fr) 1976-05-28
DD124879A5 (enrdf_load_stackoverflow) 1977-03-16
AU8628275A (en) 1977-05-12
IL48384A (en) 1979-05-31
DE2547224A1 (de) 1976-05-13
GB1529871A (en) 1978-10-25
NZ179108A (en) 1978-07-28
FI782827A7 (fi) 1978-09-14
ES442242A1 (es) 1977-08-01
DK478575A (da) 1976-05-02
NL7512590A (en) 1976-05-04
JPS5170810A (enrdf_load_stackoverflow) 1976-06-18
AU511934B2 (en) 1980-09-11

Similar Documents

Publication Publication Date Title
Alderete et al. Purification and chemical characterization of the heat-stable enterotoxin produced by porcine strains of enterotoxigenic Escherichia coli
Daniel et al. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties
Belisle et al. Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins
Kunkel et al. Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli
JP2761849B2 (ja) ポリヌクレオチド配列、組換えdna分子および形質転換体宿主
Amano et al. Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii
Lai et al. The Chemistry and Biology of Cholera Toxi
US6177085B1 (en) Generation of immune response using immunogenic conjugate of molecules
US4123427A (en) Method for the purification of mycobacterial protein antigens and resulting product
Lyampert et al. Study on streptococcus group A antigens common with heart tissue elements
AU641711B2 (en) Process for purification of a 69 000 dalton antigenetic protein from bordetella pertussis
JPH0351692B2 (enrdf_load_stackoverflow)
IE51133B1 (en) E.coli heat stable enterotoxin derivatives and preparation thereof
CA1053152A (en) Isolation and purification of e. coli enterotoxin
Stemshorn et al. The bovine immune response to Brucella abortus I. A water soluble antigen precipitated by sera of some naturally infected cattle
Keusch et al. [22] Shiga toxin: Production and purification
Kamp et al. Purification of a heat labile dermonecrotic toxin from culture fluid of Pasteurella multocida
US4228068A (en) Peptide complexes of DNA-containing organisms
Holper et al. Further studies on multiplication, serology and antigenicity of 2060 and JH viruses
Frandsen et al. Characterization of toxin from different strains of Pasteurella multocida serotype A and D
CN100406472C (zh) 一种眼镜蛇神经毒素蛋白的融合可溶表达、重组毒素的酸解释放及其生产纯化方法
Wisseman Jr et al. Gross and microscopic skin reactions to killed typhus rickettsiae in human beings
Semprevivo Exometabolites of Leishmania donovani promastigotes. I. Isolation and initial characterization
Knight et al. In vitro tests for the measurement of veterinary clostridial toxins, toxoids and antisera: I. Titration of clostridium septicum toxins and antitoxins in cell culture
Erickson et al. The cell surface antigens of Streptococcus equi